Veeda Clinical Research is a company involved in the 505(b)(2) generic drug development pathway. This regulatory approach allows for the efficient development and approval of modified or improved generic versions of existing drugs. Veeda Clinical Research engages in the submission of new drug applications (NDAs) that leverage data from studies not conducted by or for the company, while still referencing the safety and efficacy of the original drug. Contact us now!
